The Ottawa AF Cardioversion Protocol

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 389 participants.

Also called NCT02192957

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 389 participants (enrolled count) (from the registry)
Sponsor
David Birnie (from the registry)
Registry
  • NCT NCT02192957
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02192957. Allocation not applicable; no masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2017-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Ottawa AF Cardioversion Protocol
Intervention (Device)
Lifepak 20E Defibrillator, Licence No: 61944
Lead sponsor
David Birnie (class: other)

Record details

Record id
cardio:ct-nct02192957
Content hash
285548a94a5f12a0b3bebdd50d9b154659a4b5537fd1b5808cf98395da815086